Christopher Mutz, HEAD OF RARE DISEASE at ANI Pharmaceuticals, holds 76.78K shares in ANI Pharmaceuticals (Ticker: ANIP). Most recently, Christopher Mutz Sold $6,500 shares of ANI Pharmaceuticals on Nov 18, 2024 for an estimated value of 375.05K.
What is the percentage of profitable transactions made by Christopher Mutz?
The percentage of profitable transactions made by Christopher Mutz is 67%.
What is the average return per transaction made by Christopher Mutz?
The average return per transaction made by Christopher Mutz is -4.00%.
What stocks does Christopher Mutz hold?
Christopher Mutz holds: ANIP stocks.
What was Christopher Mutz’s latest transaction?
Christopher Mutz latest transaction was an Informative Sell of $375.05K.
What was Christopher Mutz's most profitable transaction?
Christopher Mutz’s most profitable transaction was an Informative Sell of ANIP stock on March 6, 2024. The return on the trade was 6.60%.
What is Christopher Mutz's role in ANI Pharmaceuticals?
Christopher Mutz's role in ANI Pharmaceuticals is HEAD OF RARE DISEASE.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.